FAMU-FSU College of Engineering researchers have created a new method for studying protein degradation within immune cells ...

Researchers at the FAMU-FSU College of Engineering have developed a novel method for investigating protein degradation in immune cells.

Bispecific antibodies first reached patients as cancer treatments, but a growing number of companies are working to expand these therapies to autoimmune diseases. Sanofi is adding a new contender ...

The white blood cell then engulfs the pathogen in a process called phagocytosis, in which it 'eats' the foreign invader to neutralize it. A vivid new image is taking shape in the world of cell ...

A comprehensive Thought Leaders Invited Review in Brain Medicine highlights the crucial role of CD2-associated protein (CD2AP ...

Financial Considerations Under the terms of the merger agreement, Sanofi will acquire DR-0201 through the acquisition of the Dren Bio affiliate Dren-0201 for an upfront payment of $600 million and ...

The white blood cell then engulfs the pathogen in a process called phagocytosis, in which it "eats" the foreign invader to neutralize it. This dramatic process might sound like something out of a ...

Sanofi to pay $600 million upfront payment to buy Dren Bio's bispecific myeloid cell engager, DR-0201: Paris Friday, March 21, 2025, 09:00 Hrs [IST] Sanofi and Dren Bio, Inc., a p ...

Sanofi and Dren Bio, Inc., a private clinical-stage biopharmaceutical company, have entered into a definitive agreement under which Sanofi has agreed to acquire DR-0201, a targeted bispecific myeloid ...